Psychosis prevalence and physical, metabolic and cognitive co-morbidity: Data from the second Australian national survey of psychosis

Psychological Medicine

Volumn 44, Issue 10, 2014, Pages 2163-2176

  Morgan, V A ^a,b   McGrath, J J ^c   Jablensky, A ^b   Badcock, J C ^a,d   Waterreus, A ^a   Bush, R ^c   Carr, V ^e,f   Castle, D ^g,h   Cohen, M ^i,j   Galletly, C ^k,l,m   Harvey, C ^g,n   Hocking, B ^o   McGorry, P ^g,p,q   Neil, A L ^r   Saw, S ^s   Shah, S ^a   Stain, H J ^t,u   MacKinnon, A ^p,q  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d Clinical Research Centre   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f Schizophrenia Research Institute   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h ST VINCENT S HOSPITAL   (Australia)

ⁱ Hunter New England Mental Health   (Australia)

^j UNIVERSITY OF NEWCASTLE   (Australia)

^k UNIVERSITY OF ADELAIDE   (Australia)

^l Ramsay Health Care   (Australia)

^m Northern Sector   (Australia)

ⁿ Psychosocial Research Centre   (Australia)

^o SANE AUSTRALIA   (Australia)

^p THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^q UNIVERSITY OF MELBOURNE   (Australia)

^r UNIVERSITY OF TASMANIA   (Australia)

^s Orygen Youth Health Research Centre ^*  (Australia)

^t UNIVERSITY OF NEWCASTLE   (Australia)

^u DURHAM UNIVERSITY   (United Kingdom)

more..

Author keywords

Bipolar disorder; Schizo affective disorder; Schizophrenia; Speed of information processing; Substance abuse

Indexed keywords

ADOLESCENT; ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; AUSTRALIA; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COMORBIDITY; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; PSYCHOTIC DISORDERS; SEDENTARY LIFESTYLE; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AFFECTIVE DISORDERS, PSYCHOTIC; AUSTRALIA; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COMORBIDITY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; PSYCHOTIC DISORDERS; SEDENTARY LIFESTYLE; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84902334435     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713002973     Document Type: Article

References (73)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC (2009). Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645
2. Alonzo TA, Pepe MS, Lumley T (2003). Estimating disease prevalence in two-phase studies. Biostatistics 4, 313-326
3. Australian Bureau of Statistics (2008). National Survey of Mental Health and Wellbeing 2007. Catalogue no. 4326.0
4. Australian Bureau of Statistics: Canberra. Australian Schizophrenia Research Bank (2011). Customised data provided by the Australian Schizophrenia Research Bank (http://www.schizophreniaresearch.org.au/bank/) which is supported by the National Health and Medical Research Council of Australia, the Pratt Foundation; Ramsay Health Care and the Schizophrenia Research Institute
5. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2001). AUDIT. The Alcohol Use Disorders Identification Test. Guidelines For Use in Primary Care, 2nd edn. WHO/MSD/ 01.6a. World Health Organization: Geneva
6. Berns S, Uzelac S, Gonzalez C, Jaeger J (2007). Methodological considerations of measuring disability in bipolar disorder: Validity of the Multidimensional Scale of Independent Functioning. Bipolar Disorders 9, 3-10. (Pubitemid 46671668
7. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006). Risk of dementia in Diabetes mellitus: A systematic review. Lancet Neurology 5, 64-74. (Pubitemid 41790697
8. Bobes J, Arango C, Garcia-Garcia M, Rejas J (2010). Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophrenia Research 119, 101-109
9. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005). The effects of type 1 diabetes on cognitive performance: A meta-Analysis. Diabetes Care 28, 726-735. (Pubitemid 40315341
10. Castle D, Jablensky A, McGrath J, Carr V, Morgan VA, Waterreus A, Valuri G, Stain H, McGuffin P, Farmer A (2006). The Diagnostic Interview for Psychoses (DIP): Development, reliability and applications. Psychological Medicine 36, 69-80. (Pubitemid 41825347
11. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003). International Physical Activity Questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise 35, 1381-1395. (Pubitemid 36936159
12. Crawford JR, Deary IJ, Starr J, Whalley LJ (2001). The NART as an index of prior intellectual functioning: A retrospective validity study covering a 66-year interval. Psychological Medicine 31, 451-458. (Pubitemid 32294043
13. Daumit GL, Dickerson FB, Wang NY, Dalcin A, Jerome GJ, Anderson CA, Young DR, Frick KD, Yu A, Gennusa JV III, Oefinger M, Crum RM, Charleston J, Casagrande SS, Guallar E, Goldberg RW, Campbell LM, Appel LJ (2013). A behavioral weight-loss intervention in persons with serious mental illness. New England Journal of Medicine 368, 1594-1602
14. De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Moller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S (2011). Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10, 52-77
15. Dickinson D, Gold J, Dickerson F, Medoff D, Dixon L (2008). Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes. Psychosomatics 49, 123-131. (Pubitemid 351364986
16. Dickinson D, Ramsey ME, Gold JM (2007). Overlooking the obvious: A meta-Analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry 64, 532-542. (Pubitemid 46718286
17. Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V (2013). The dietary pattern of patients with schizophrenia: A systematic review. Journal of Psychiatric Research 47, 197-207
18. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, Wojcicki TR, Mailey E, Vieira VJ, Martin SA, Pence BD, Woods JA, McAuley E, Kramer AF (2011). Exercise training increases size of hippocampus and improves memory. Proceedings of the National Academy of Sciences 108, 3017-3022
19. Galletly CA, Foley DL, Waterreus A, Watts GF, Castle DJ, McGrath JJ, Mackinnon A, Morgan VA (2012). Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry 46, 753-761
20. Gao L, Matthews FE, Sargeant LA, Brayne C (2008). An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: From a population based multi-centre longitudinal study. BMC Public Health 8, 54
21. Gold JM (2004). Cognitive deficits as treatment targets in schizophrenia. Schizophrenia Research 72, 21-28
22. Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF (2002). Cognitive correlates of job tenure among patients with severe mental illness. American Journal of Psychiatry 159, 1395-1402. (Pubitemid 34832723
23. Green MF, Kern RS, Braff DL, Mintz J (2000). Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the 'right stuff'?. Schizophrenia Bulletin 26, 119-136
24. Han M, Huang XF, Chen Da C, Xiu M, Kosten TR, Zhang XY (2013). Diabetes and cognitive deficits in chronic schizophrenia: A case-control study. PLOS ONE 8, e66299
25. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström K-O (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction to Alcohol and Other Drugs 86, 1119-1127
26. Heinrichs RW, Ammari N, Miles AA, McDermid Vaz S (2010). Cognitive performance and functional competence as predictors of community independence in schizophrenia. Schizophrenia Bulletin 36, 381-387
27. International Diabetes Federation (2006). The IDF Consensus Worldwide Definition of the Metabolic Syndrome. International Diabetes Federation: Brussels
28. Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Morgan VA, Korten A, Harvey C (2000). Psychotic disorders in urban areas: An overview of the Study on Low Prevalence Disorders. Australian and New Zealand Journal of Psychiatry 34, 221-236. (Pubitemid 30206762
29. Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Morgan VA, Korten A, on behalf of the Low Prevalence Disorders Study Group (1999). People Living with Psychotic Illness: An Australian Study 1997-98
30. National Survey of Mental Health and Wellbeing: Report 4. National Mental Health Strategy. Mental Health Branch, Australian Commonwealth Department of Health and Aged Care: Canberra (http://www.health. gov.au/internet/main/ publishing.nsf/Content/ 7D5BDF162FA03C76CA257BF0001C1B7D/$File/psych.pdf) . Accessed 28 November 2013
31. Jablensky AJ, Kirkbride JB, Jones PB (2011). The epidemiological horizon. In Schizophrenia (ed. D. R. Weinberger and P. J. Harrison), pp. 185-225. Wiley-Blackwell: Oxford
32. Jaeger J, Berns SM, Czobor P (2003). The multidimensional scale of independent functioning: A new instrument for measuring functional disability in psychiatric populations. Schizophrenia Bulletin 29, 153-168
33. Jerrell JM, McIntyre RS, Black GB (2012). Economic grand rounds: Economic costs of failure to monitor adverse effects of second-generation antipsychotics: An underestimated factor. Psychiatric Services 63, 202-204
34. John AP, Koloth R, Dragovic M, Lim SC (2009). Prevalence of metabolic syndrome among Australians with severe mental illness. Medical Journal of Australia 190, 176-179
35. Jones DT (2012). Neural networks, cognition, and diabetes: What is the connection?. Diabetes 61, 1653-1655
36. Julious SA (2004). Using confidence intervals around individual means to assess statistical significance between two means. Pharmaceutical Statistics 3, 217-222
37. Kessler RC, Angermeyer M, Anthony JC, De Graaf R, Demyttenaere K, Gasquet I, De Girolamo G, Gluzman S, Gureje O, Haro JM, Kawakami N, Karam A, Levinson D, Mora MEM, Oakley Browne MA, Posada-Villa J, Stein DJ, Tsang CHA, Aguilar-Gaxiola S, Alonso J, Lee S, Heeringa S, Pennell B-E, Berglund P, Gruber MJ, Petukhova M, Chatterji S, Üstün TB, on behalf of the WHO World Mental Health Survey Consortium (2007). Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 6, 168-176
38. Khandaker GM, Barnett JH, White IR, Jones PB (2011). A quantitative meta-Analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Research 132, 220-227
39. Kodesh A, Goldshtein I, Gelkopf M, Goren I, Chodick G, Shalev V (2012). Epidemiology and co-morbidity of severe mental illnesses in the community: Findings from a computerized mental health registry in a large Israeli health organization. Social Psychiatry and Psychiatric Epidemiology 47, 1775-1782
40. Laursen TM (2011). Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophrenia Research 131, 101-104
41. Lawrence D, Hancock KJ, Kisely S (2013). The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: Retrospective analysis of population based registers. British Medical Journal 346, f2539
42. Lawrence D, Holman C, Jablensky A (2001). Duty to Care. Preventable Physical Illness in People with Mental Illness. The University of Western Australia: Perth
43. Lawrence D, Kisely S (2010). Inequalities in healthcare provision for people with severe mental illness. Journal of Psychopharmacology 24, 61-68
44. Leucht S, Lasser R (2006). The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 39, 161-170. (Pubitemid 44369175
45. Lindenmayer JP, Khan A, Kaushik S, Thanju A, Praveen R, Hoffman L, Cherath L, Valdez G, Wance D (2012). Relationship between metabolic syndrome and cognition in patients with schizophrenia. Schizophrenia Research 142, 171-176
46. Maudsley H (1879). The Pathology of Mind. Macmillan: London
47. McGuffin PC, Farmer A, Harvey I (1991). A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of General Psychiatry 48, 764-770
48. Meyer JM, Nasrallah HA, McEvoy JP, Goff DC, Davis SM, Chakos M, Patel JK, Keefe RS, Stroup TS, Lieberman JA (2005). The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome. Schizophrenia Research 80, 9-18. (Pubitemid 41587459
49. Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M (2013). Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders - A systematic review and meta-Analysis. Schizophrenia Bulletin 39, 306-318
50. Morgan VA, Waterreus A, Jablensky A, Mackinnon A, McGrath J, Carr V, Bush R, Castle D, Cohen M, Harvey C, Galletly C, Stain H, Neil A, McGorry P, Hocking B, Shah S, Saw S (2011). People Living with Psychotic Illness 2010. Report on the Second Australian National Survey. Australian Government Department of Health and Ageing: Canberra
51. Morgan VA, Waterreus A, Jablensky A, Mackinnon A, McGrath JJ, Carr V, Bush R, Castle D, Cohen M, Harvey C, Galletly C, Stain HJ, Neil AL, McGorry P, Hocking B, Shah S, Saw S (2012). People living with psychotic illness in 2010: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry 46, 735-752
52. Morrison G, Sharkey V, Allardyce J, Kelly RC, McCreadie RG (2000). Nithsdale schizophrenia surveys 21: A longitudinal study of National Adult Reading Test stability. Psychological Medicine 30, 717-720. (Pubitemid 30410333
53. Nelson HE, Willison J (1991). National Adult Reading Test (NART): Test Manual, 2nd edn. NFER Nelson:Windsor, UK
54. Nielsen RE, Uggerby AS, Jensen SOW, McGrath JJ (2013). Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades - A Danish nationwide study from 1980 to 2010. Schizophrenia Research 146, 22-27
55. Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A, D'Onofrio G, Seripa D, Sancarlo D, Pilotto A, Solfrizzi V (2010). Metabolic syndrome and cognitive impairment: Current epidemiology and possible underlying mechanisms. Journal of Alzheimer's Disease 21, 691-724
56. Perälä J, Suvisaari J, Saarni S, Kuoppasalmi K, Isometsä E, Pirkola S, Partonen T, Tuulio-Henriksson A, Hintikka J, Kieseppä T, Härkänen T, Koskinen S, Lönnqvist J (2007). Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry 64, 19-28
57. Pickles A, Dunn G, Vázquez-Barquero JL (1995). Screening for stratification in two-phase ('two-stage') epidemiological surveys. Statistical Methods in Medical Research 4, 73-89
58. Randolph C (1998). Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Test Manual. Harcourt Brace and Company: San Antonio
59. Reichenberg A, Weiser M, Rapp MA, Rabinowitz J, Caspi A, Schmeidler J, Knobler HY, Lubin G, Nahon D, Harvey PD, Davidson M (2005). Elaboration on premorbid intellectual performance in schizophrenia: Premorbid intellectual decline and risk for schizophrenia. Archives of General Psychiatry 62, 1297-1304. (Pubitemid 41746607
60. Saha S, Chant D, McGrath J (2007). A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time?. Archives of General Psychiatry 64, 1123-1131
61. Saha S, Chant DC, Welham JL, McGrath J (2005). A systematic review of the prevalence of schizophrenia. PLoS Medicine 2, e141
62. Smith D, Roberts S, Brewer W, Pantelis C (1998). Test-retest reliability of the National Adult Reading Test (NART) as an estimate of premorbid IQ in patients with schizophrenia. Cognitive Neuropsychiatry 3, 71-80. (Pubitemid 128534196
63. Tirupati S, Chua L-E (2007). Obesity and metabolic syndrome in a psychiatric rehabilitation service. Australian and New Zealand Journal of Psychiatry 41, 606-610. (Pubitemid 46930098
64. Verhaeghe N, De Maeseneer J, Maes L, Van Heeringen C, Annemans L (2011). Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: A systematic review. International Journal of Behavioral Nutrition and Physical Activity 8, 28
65. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez M-G, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT-A, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, Courville de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Eltahir Ali S, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FGR, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo J-P, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Ma J, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer A-C, Miglioli V, Miller M, Miller TR, Mitchell PB, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KMV, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian J, Panozo Rivero A, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, Rodriguez De Leòn F, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJC, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van Der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams SRM, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh P-H, Zaidi AKM, Zheng Z-J, Zonies D, Lopez AD, Murray CJL (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2163-2196
66. Wildgust HJ, Beary M (2010). Review: Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?. Journal of Psychopharmacology 24, 37-50
67. Wilk CM, Gold JM, Bartko JJ, Dickerson F, Fenton WS, Knable M, Randolph C, Buchanan RW (2002). Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. American Journal of Psychiatry 159, 838-844. (Pubitemid 34465059
68. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablensky A, Regier D, Sartorius N (1990). SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry 47, 589-593. (Pubitemid 20189971
69. Woodberry KA, Giuliano AJ, Seidman LJ (2008). Premorbid IQ in schizophrenia: A meta-Analytic review. American Journal of Psychiatry 165, 579-587. (Pubitemid 351705334
70. World Health Organization (2009). Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. World Health Organization: Geneva
71. World Health Organization (2000). Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series no. 894. World Health Organization: Geneva
72. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P (2011). A meta-Analysis of cognitive remediation for schizophrenia: Methodology and effect sizes. American Journal of Psychiatry 168, 472-485
73. Zammit S, Allebeck P, David AS, Dalman C, Hemmingsson T, Lundberg I, Lewis G (2004). A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Archives of General Psychiatry 61, 354-360. (Pubitemid 38451544.